
Aptinyx
Biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system.
Market cap
$6.5m
Enterprise value
($11m)
Share price
$0.06 APTX
Authorizing premium user...
Biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system.